About Bgi Genomics
BGI Genomics is a subsidiary of the BGI Group, one of the world’s largest genomics enterprises headquartered in Shenzhen, China. The company specializes in next‑generation sequencing (NGS) and a broad spectrum of multi‑omics services, positioning itself as a global leader in genomic and proteomic research and diagnostics. BGI Genomics offers high‑throughput, cost‑effective gene expression sequencing, whole‑genome sequencing (WGS), and targeted panel sequencing for academic, pharmaceutical, biotechnology, and clinical laboratories. Its portfolio extends to proteomics, metabolomics, and integrated multi‑omics solutions that enable comprehensive biomarker discovery and precision medicine research.
The firm’s service model is built around end‑to‑end genomic workflows: sample collection, library preparation, sequencing on proprietary and Illumina platforms, and advanced bioinformatics pipelines that deliver actionable data. BGI Genomics partners with institutions such as Unilabs and Science Exchange to broaden access to its technologies across Europe and the Americas, and it collaborates with Natera to commercialize the Signatera assay for cancer monitoring. The company’s clientele spans more than 66 countries, including academic institutions, hospitals, biotech startups, and large pharmaceutical companies.
Key differentiators include BGI Genomics’ ability to deliver high‑quality sequencing at competitive prices, its extensive global network of laboratories, and its integration of cutting‑edge informatics tools that streamline data analysis and interpretation. The company’s business model focuses on B2B service provision, generating revenue through sequencing contracts, data analysis subscriptions, and assay commercialization agreements. With a strong emphasis on innovation, BGI Genomics continues to expand its service offerings, invest in new sequencing technologies, and support the growing demand for genomic data in research, diagnostics, and drug development.
Company facts
- Industry
- Biotechnology
- Sub-industries
- Genomics, Proteomics, Bioinformatics, Clinical Diagnostics, Multi-Omics, Sequencing, Genomic Services
- Location
- Cambridge, United States
- Employees
- 11–50
- Revenue (USD)
- 1–5M
- Founded
- 1999
Products and services
Open Bgi Genomics in GlobalDeal Is this your company? Update the details for free
More Biotechnology companies in United States
- Gilead Sciences
Gilead Sciences, Inc. is a biopharmaceutical company that discovers, develops, and commercializes innovative medicines in areas of unmet medical need. Founded in 1987 and… - Uw School Of Medicine And Public Health
The University of Wisconsin School of Medicine and Public Health (UWSMPH) is a leading institution dedicated to improving health through education, research, and service. It… - Agilent Technologies
Agilent Technologies, Inc. is a global leader in life sciences, diagnostics, and applied chemical markets. The company provides instruments, software, services, and consumables… - Genentech
Genentech, a member of the Roche Group, is a leading biotechnology company that discovers, develops, manufactures, and commercializes medicines to treat patients with serious and… - Envigo
Envigo is a global provider of essential products and services for the research and development of new drugs and therapies. The company specializes in the breeding and supply of… - Illumina
Illumina, Inc. is a global leader in genomics, focused on developing innovative technologies for genetic analysis. Founded in 1998 and headquartered in San Diego, California… - Bio-Rad Laboratories
Bio-Rad Laboratories, Inc. is a global leader in life science research and clinical diagnostics. Founded in 1952, the company develops, manufactures, and markets a broad range of… - Csl Behring
CSL Behring is a global biotechnology leader that develops and delivers innovative therapies for people with serious and rare diseases. The company specializes in the development… - Baxalta
Baxalta Incorporated was a global biopharmaceutical company that focused on developing and delivering innovative therapies for people with hemophilia, immune deficiencies, and… - Novonesis
Novonesis is a biotechnology company focused on developing innovative solutions for healthcare challenges. The company specializes in the research and development of biologics… - Celgene
Celgene Corporation, now a subsidiary of Bristol-Myers Squibb, is a biopharmaceutical company that discovers, develops, and commercializes innovative therapies for the treatment… - Synthego Corporation
Synthego Corporation is a leading provider of synthetic biology solutions, specializing in CRISPR technology and genome engineering. Founded in 2014, the company aims to…